Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma, CRO)-Global Forecast to 2026

Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma, CRO)-Global Forecast to 2026

The global pharmaceutical contract development and manufacturing market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in advanced manufacturing technologies by CDMOs. The increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements in cell and gene therapies are also expected to offer market growth opportunities in the coming years.

“The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market, byend user, during the forecast period”

The pharmaceutical contract development and manufacturing market is segmented intobig pharmaceutical companies, small & medium-sized pharmaceutical companies, generic pharmaceutical companies, and other end users. The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market in 2021. This segment's high growth can be attributed to the increasing number of emerging pharmaceutical companies that lack the in-house capabilities to manufacture and develop complex formulations and drug products.

“Biologics manufacturing services segment accounted for the highest CAGR”

Based on service, the pharmaceutical contract development and manufacturing market is segmented into pharmaceutical manufacturing, biologics manufacturing, and drug development services. In 2021, the biologics manufacturing services segment accounted for the highest growth rate. The major factor driving the growth of this segment is the growing demand for vaccines and biosimilars.

“Asia Pacific: The fastest-growing countryin thepharmaceutical contract development and manufacturing market”

Thepharmaceutical contract development and manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to register the highest CAGR during the forecast period. This growth can be attributed to factors such as growth in the manufacturing sector, favorable government regulations, growing strategic expansions from leading companies, increasing emphasis on off-patent drugs, and the presence of a highly skilled workforce.

The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 80%and Demand Side 20%
By Designation: C-level - 25%, D-level - 20%, and Others - 55%
By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

Lists of Companies Profiled in the Report:
Thermo Fisher Scientific Inc. (US)
Catalent, Inc. (US)
Lonza Group Ltd. (Switzerland)
Recipharm AB (Sweden)
Siegfried Holding AG (Switzerland)
WuXiAppTec (China)
Samsung Biologics (South Korea)
Boehringer Ingelheim International GmbH (Germany)
Piramal Pharma Solutions (India)
Vetter Pharma International GmbH (Germany)
FAMAR Health Care Services (France)
AbbVie Inc. (US)
Aenova Group (Germany)
Almac Group (UK)
Evonik Industries AG (Germany)
Cambrex Corporation (US)
CordenPharma International (Germany)
Albany Molecular Research Inc. (AMRI) (US)
FUJIFILM Corporation (Japan)
BioVectra (Canada)

Research Coverage:

This report provides a detailed picture of thepharmaceutical contract development and manufacturing market. It aims at estimating the size and future growth potential of the market across different segments,such as the service, end user, and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical contract development and manufacturing marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH APPROACH
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET DATA ESTIMATION & TRIANGULATION
    • MARKET ESTIMATION METHODOLOGY
    • GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • INSIGHTS FROM PRIMARIES
    • RESEARCH ASSUMPTIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET OVERVIEW
    • EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
    • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER
    • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • OPPORTUNITIES
      • CHALLENGES
      • TRENDS
        • Table LIST OF ACQUISITIONS
    • VALUE CHAIN ANALYSIS
    • ECOSYSTEM MARKET MAP
    • SUPPLY CHAIN
    • IMPACT OF THE COVID-19 PANDEMIC ON THE GROWTH OF THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
      • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
      • IMPACT ON THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
    • REGULATORY ASSESSMENT
      • INTRODUCTION
    • PORTERS FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • DEGREE OF COMPETITION
  • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE
    • INTRODUCTION
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
    • PHARMACEUTICAL MANUFACTURING SERVICES
      • Table PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
      • Table PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
      • PHARMACEUTICAL API MANUFACTURING SERVICES
        • Table PHARMACEUTICAL API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table PHARMACEUTICAL API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
      • PHARMACEUTICAL FDF MANUFACTURING SERVICES
        • Table PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table PARENTERAL/INJECTABLE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table PARENTERAL/INJECTABLE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
        • Table TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
        • Table CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
        • Table ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
        • Table SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
        • Table OTHER FORMULATIONS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table OTHER FORMULATIONS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    • DRUG DEVELOPMENT SERVICES
      • DRUG SUBSTANCE COMPLEXITY AND HIGH COSTS HAVE SUPPORTED THE OUTSOURCING OF DRUG DEVELOPMENT
        • Table DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    • BIOLOGICS MANUFACTURING SERVICES
      • Table BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • BIOLOGICS API MANUFACTURING SERVICES
        • Table BIOLOGICS API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table BIOLOGICS API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
      • BIOLOGICS FDF MANUFACTURING SERVICES
        • Table BIOLOGICS FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table BIOLOGICS FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER
    • INTRODUCTION
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
    • BIG PHARMACEUTICAL COMPANIES
      • EMERGENCE OF NEW MEDICINES AND THERAPIES TO CONTRIBUTE TO THE GROWTH OF THIS MARKET
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
    • SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES
      • DEMAND IN BIOLOGICS DRUG DEVELOPMENT AND HIGH PRICING PRESSURE TO BOOST THE MARKET GROWTH
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
    • GENERIC PHARMACEUTICAL COMPANIES
      • GROWING DEMAND FOR GENERICS TO SUPPORT MARKET GROWTH
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
    • OTHER END USERS
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2020 (USD MILLION)
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)
  • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY REGION
    • INTRODUCTION
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY REGION, 2017–2020 (USD MILLION)
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY REGION, 2021–2026 (USD MILLION)
    • EUROPE
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table EUROPE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table EUROPE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • GERMANY
        • Table GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table GERMANY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table GERMANY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • ITALY
        • Table ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ITALY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ITALY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • FRANCE
        • Table FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table FRANCE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table FRANCE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • UK
        • Table UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table UK: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table UK: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table UK: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table UK: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table UK: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table UK: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • SWITZERLAND
        • Table SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SWITZERLAND: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SWITZERLAND: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • SPAIN
        • Table SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SPAIN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SPAIN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • POLAND
        • Table POLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table POLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table POLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table POLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table POLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table POLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table POLAND: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table POLAND: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table POLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table POLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table ROE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ROE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ROE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ROE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ROE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ROE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table NORTH AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table NORTH AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • US
        • Table US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table US: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table US: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table US: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table US: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table US: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table US: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • CANADA
        • Table CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table CANADA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table CANADA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table ASIA PACIFIC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
      • Table ASIA PACIFIC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • CHINA
        • Table CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table CHINA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table CHINA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • INDIA
        • Table INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table INDIA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table INDIA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table SOUTH KOREA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table SOUTH KOREA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SOUTH KOREA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SOUTH KOREA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SOUTH KOREA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table SOUTH KOREA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table SOUTH KOREA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
      • JAPAN
        • Table JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table JAPAN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table JAPAN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ROAPAC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table ROAPAC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
    • LATIN AMERICA
      • FAVORABLE COST STRUCTURE AND GOVERNMENT INVESTMENTS TO DRIVE PHARMACEUTICAL PRODUCTION IN LATAM
        • Table LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table LATIN AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table LATIN AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • GOVERNMENT SUPPORT TO BOOST LOCAL PRODUCTION IS EXPECTED TO OFFER GROWTH OPPORTUNITIES FOR CONTRACT MANUFACTURERS IN THE REGION
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017–2020 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2021–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017–2020 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2021–2026 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • MARKET SHARE ANALYSIS
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: DEGREE OF COMPETITION
    • COMPETITIVE LEADERSHIP MAPPING
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: START-UP/SME EVALUATION MATRIX, 2020
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPANY SERVICE FOOTPRINT
      • Table SERVICE PORTFOLIO ANALYSIS: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
    • COMPANY GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
      • Table GEOGRAPHIC REVENUE MIX: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET (2020)
    • COMPETITIVE SCENARIO
      • SERVICE LAUNCHES
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: SERVICE LAUNCHES, MAY 2019–OCTOBER 2020
      • DEALS
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: DEALS, MARCH 2019–AUGUST 2021
      • OTHERS
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: OTHERS, MAY 2019–AUGUST 2021
  • COMPANY PROFILES
    • MAJOR PLAYERS
      • LONZA GROUP
        • Table LONZA GROUP: BUSINESS OVERVIEW
        • Table LONZA GROUP: SERVICES OFFERED
      • THERMO FISHER SCIENTIFIC INC.
        • Table THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
        • Table THERMO FISHER SCIENTIFIC: SERVICES OFFERED
      • CATALENT
        • Table CATALENT: BUSINESS OVERVIEW
        • Table CATALENT: SERVICES OFFERED
      • RECIPHARM AB
        • Table RECIPHARM AB: BUSINESS OVERVIEW
        • Table RECIPHARM AB: SERVICES OFFERED
      • ABBVIE
        • Table ABBVIE: BUSINESS OVERVIEW
        • Table ABBVIE: SERVICES OFFERED
      • SIEGFRIED HOLDING AG
        • Table SIEGFRIED HOLDING AG: BUSINESS OVERVIEW
        • Table SIEGFRIED HOLDING AG: SERVICES OFFERED
      • EVONIK INDUSTRIES
        • Table EVONIK INDUSTRIES: BUSINESS OVERVIEW
        • Table EVONIK INDUSTRIES: SERVICES OFFERED
      • BOEHRINGER INGELHEIM
        • Table BOEHRINGER INGELHEIM: BUSINESS OVERVIEW
        • Table BOEHRINGER INGELHEIM: SERVICES OFFERED
      • PIRAMAL PHARMA SOLUTIONS
        • Table PIRAMAL PHARMA SOLUTIONS: BUSINESS OVERVIEW
        • Table PIRAMAL PHARMA SOLUTIONS: SERVICES OFFERED
      • SAMSUNG BIOLOGICS
        • Table SAMSUNG BIOLOGICS: BUSINESS OVERVIEW
        • Table SAMSUNG BIOLOGICS: SERVICES OFFERED
      • WUXI APPTEC (WUXI STA)
        • Table WUXI APPTEC: BUSINESS OVERVIEW
        • Table WUXI APPTEC: SERVICES OFFERED
      • FUJIFILM HEALTHCARE
        • Table FUJIFILM HEALTHCARE: BUSINESS OVERVIEW
        • Table FUJIFILM HEALTHCARE: SERVICES OFFERED
    • OTHER PLAYERS
      • VETTER PHARMA INTERNATIONAL
        • Table VETTER PHARMA INTERNATIONAL: BUSINESS OVERVIEW
        • Table VETTER PHARMA INTERNATIONAL: SERVICES OFFERED
      • FAMAR HEALTH CARE SERVICES
        • Table FAMAR HEALTH CARE SERVICES: BUSINESS OVERVIEW
        • Table FAMAR HEALTH CARE SERVICES: SERVICES OFFERED
      • AENOVA GROUP
        • Table AENOVA GROUP: BUSINESS OVERVIEW
        • Table AENOVA GROUP: SERVICES OFFERED
      • ALMAC GROUP
      • CAMBREX
      • CORDENPHARMA
      • BIOVECTRA
      • CURIA (FORMERLY ALBANY MOLECULAR RESEARCH)
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook